Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy

Annals of Pharmacotherapy

Volumn 28, Issue 9, 1994, Pages 1031-1034

  Bourget, Philippe ^a   Pons, Jean Claude ^b   Delouis, Christine ^b   Fermont, Laurent ^b   Frydman, René ^b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b Department of Gynecology and Obstetrics ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; FETUS; FETUS DISEASE; HEART FAILURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYDRAMNIOS; KIDNEY CLEARANCE; LIVER CLEARANCE; PLACENTAL TRANSFER; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY;

ADULT; AMNIOTIC FLUID; CASE REPORT; COMPARATIVE STUDY; FEMALE; FETAL MONITORING; FLECAINIDE; HUMAN; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 0028128508     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809402800907     Document Type: Article

References (17)

1. Nappi JM Anderson JL. Flecainide: A new prototype antiarrhythmic agent. Pharmacotherapy 1985; 5: 209–18.
2. Wren C Hunter S. Maternal administration of flecainide to terminate and suppress fetal tachycardia. Br Med J 1988; 90: 55.
3. Allen LD Chita SK Sharland GK Maxwell D Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991; 65: 46–48.
4. Kofinas AD Simon NV Sagel H Lyttle E Smith N King K. Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure. Am J Obstet Gynecol 1991; 165: 630–1.
5. Perry JC Ayres NA Carpenter RJ. Fetal supraventricular tachycardia treated with flecainide acetate. J Pediatr 1991; 118: 303–5.
6. Wagner X Jouglard J Moulin M Miller AM Petitjean J Pisapia A. Coadministration of flecainide acetate and sotalol during pregnancy: Lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J 1990; 119: 700–2.
7. Palmer CM. Placental transfer of flecainide. Am J Dis Child 1990; 144: 144.
8. McQuinn RL Pisani A Wafa S Chang SF Miller AM Frappell JM, Flecainide excretion in human breast milk. Clin Pharmacol Ther 1990; 48: 262–7.
9. Conard GJ Ober RE. Metabolism of flecainide. Am J Cardiol 1984; 53 (suppl): 41B–51B.
10. Straka RJ Hoon TJ Lalonde RL Pieper JA Bottoroff MB. Liquid chromatography and fluorescence polarization immunoassay methods compared for measuring flecainide acetate in serum. Clin Chem 1987; 33: 1898–900.
11. TDxFLx assays manual. Abbott Park, IL: Abbott Laboratories, 1992.
12. Rowland M Tozer T. Clinical pharmacokinetics: Concept and applications. Philadelphia: Lea and Febiger, 1980.
13. Perry JC McQuinn RL Smith RT Gothing C Fredell P Garson A. Flecainide acetate for arrhythmias in the young: Efficacy and pharmacokinetics. J Am Coll Cardiol 1989; 14: 185–91.
14. Bourget P Fernandez H Papiernik E. Transplacental passage of cyclosporin A after liver transplantation. Transplantation 1990; 49: 663.
15. Fernandez H Bourget P Delouis C. Fetal levels of tobramycin following maternal administration. Obstet Gynecol 1990; 76: 1190–3.
16. Bourget P Fernandez H Delouis C. Accumulation of cyclosporine in the conceptus during the first trimester of pregnancy after liver transplantation. Transplantation 1991; 51: 1306–7.
17. Bourget P Fernandez H Delouis C Ribou F. Transplacental passage of vancomycin during the second trimester of pregnancy. Obstet Gynecol 1991; 78: 908–11.